HONG KONG,Feb. 27,2025-- Akeso,Inc. (9926.HK) announced the first patient has been enrolled in the Phase I clinical trial of AK138 D1 for the treatment of advanced malignancies in Australia. AK138D1,a
- Four Ragnarok Titles Poised to Captivate Gamers Across the Region! SINGAPORE,Feb. 27,2025-- Global gaming company Gravity is set to expand its presence in Southeast Asia by introducing four newRagna
XIAMEN,China,Feb. 27,2025-- Lichen China Limited (Nasdaq: LICN)("Lichen China" or the "Company"),a dedicated financial and taxation service provider inChina today announcedthe date
ASHBURN,Va.,Feb. 27,2025-- DXC Technology (NYSE: DXC),a leading Fortune 500 global technology services provider,today announced the appointment of Pat McClanahan as Global Leader of Business and Sale
The First-of-Its-Kind Mini Tri-Fold That Transforms From a Smartphone to a Hands-Free Display and a Compact Camera
DALLAS,Feb. 27,2025--Sekisui Specialty Chemicals is proud to announce that it has earned the International Sustainability and Carbon Certification (ISCC PLUS) for a broad suite of its Selvol™ Polyvin